Aerosol antibiotic treatment in cystic fibrosis.

Aerosol antibiotic treatment in cystic fibrosis.

The outlook for people with cystic fibrosis has improved steadily since the first descripition of the disease in the late 1930s. A major reason for the improved prognosis has been the availability and effective use of antibiotics to delay the onset, and slow the progress, of the inevitable bronchopulmonary bacterial colonisation and infection that will eventually prove fatal. During the 1970s a...

Antibiotic Treatment for cystic fibrosis

Aerosol therapy in cystic fibrosis.

An aerosol is defined as a suspension of liquid or solid particles in air or oxygen, and the process of forming an aerosol is called nebulization. Therapeutically an aerosol may be inhaled and may, but does not necessarily, contain mucolytic, therapeutic, or antibiotic agents. Common usage of aerosol in medicine usually means intermittent inhalation by face mask or oral tube. Mist tents are aer...

Aerosol antibiotics in cystic fibrosis.

Chronic airways infection and inflammation is the greatest source of morbidity and mortality in cystic fibrosis (CF) patients. Many organisms can be found in the lower respiratory tract of CF patients, but infection with mucoid Pseudomonas aeruginosa is common, is associated with poorer outcomes, and is the main target for antimicrobial strategies in CF. Aerosol antibiotics achieve high local c...

Antibiotic Susceptibility of Pseudomonas Aeruginosa Isolated from Cystic Fibrosis Patients

Abstract Background and Objective: Cystic fibrosis (CF) is an autosomal recessive genetic disease and Pseudomonas aeruginosa is one of the most common bacteria colonized in CF patients. Growing resistance of this bacterium to antibiotics now a day is a challenge of controlling infection in CF patient. In this study colonization of CF patients with Pseudomonas aeruginosa and antibiotic suscep...